A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma
Clinical trial NCT02685826 · COMPLETED
Trial details
- NCT number
- NCT02685826
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-25
- Primary completion
- 2017-12-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.